From: A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal
Analyte
Concentration (ng/mL)
Recovery (%)
Matrix effect (%)
Mean ± SD
RSD(%)
Zanubrutinib
2
92.0 ± 10.2
11.1
104.4 ± 9.9
9.5
40
98.2 ± 11.4
11.6
97.5 ± 6.0
6.1
800
97.0 ± 5.8
6.0
106.3 ± 6.6
6.2